<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="97555">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02038257</url>
  </required_header>
  <id_info>
    <org_study_id>8082</org_study_id>
    <nct_id>NCT02038257</nct_id>
  </id_info>
  <brief_title>Comparative Study Using Dermabrasion vs CO2 Laser &amp; Collagen Dressing vs Vaseline Gauze in MKTP</brief_title>
  <acronym>MKTP</acronym>
  <official_title>Prospective Open Label Parallel Study Comparing Use of Carbon Dioxide Laser Versus Dermabrasion for Denuding Epithelium and Collagen Dressing Versus Vaseline Impregnated Gauze for the Melanocyte Keratinocyte Transplant Procedure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Henry Ford Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Henry Ford Health System</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to:

        1. Compare two different techniques in the melanocyte keratinocyte transplant procedure:
           Use of carbon dioxide laser versus use of dermabrasion

        2. Compare two different dressings in the melanocyte keratinocyte transplant procedure:
           vaseline impregnated gauze versus collagen dressing
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The melanocyte keratinocyte transplant procedure (MKTP) has been shown to be effective in
      treating vitiligo and other conditions with depigmented skin.  MKTP involves the
      transplantation of melanocytes and keratinocytes from normal skin onto the depigmented skin
      in order to repigment the skin.

      Both dermabrasion and carbon dioxide lasers have been used effectively in MKTP to denude the
      epithelium.  This study will compare the efficacy of these two techniques.

      The study will also compare the efficacy of two different dressings used in MKTP, vaseline
      impregnated gauze and collagen dressings.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">July 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Vitiligo Assessment Scoring Index (VASI)</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Assessment of the percentage of repigmentation and color match of the repigmentation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to De-Epithelialization</measure>
    <time_frame>Assessed at Visit 1 (Day of Procedure)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Amount of time needed to de-epithelialize the skin using carbon dioxide laser versus dermabrasion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Severity Scale</measure>
    <time_frame>Assessed on Visit 1 (Day of Procedure)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Assess pain experienced on a severity scale from 0-10 during de-epithelialization with carbon dioxide laser versus dermabrasion, and during dressing application with vaseline impregnated gauze versus collagen dressing.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Vitiligo</condition>
  <condition>Depigmented Scars</condition>
  <condition>Depigmentation</condition>
  <arm_group>
    <arm_group_label>MKTP with CO2 Laser/Collagen Dressing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each Subject will have a depigmented patch of skin treated with MKTP using the carbon dioxide laser for de-epithelialization and a collagen dressing for the wound dressing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MKTP with CO2 laser/vaseline gauze</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each subject will have a depigmented patch of skin treated with MKTP using the carbon dioxide laser for de-epithelialization and vaseline impregnated gauze as the wound dressing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MKTP with dermabrasion/collagen dressing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each subject will have a depigmented patch of skin treated with MKTP using dermabrasion for de-epithelialization and a collagen dressing for the wound dressing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MKTP with dermabrasion/vaseline gauze</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each subject will have a depigmented patch of skin treated with MKTP using dermabrasion for de-epithelialization and vaseline impregnated gauze as a wound dressing.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>MKTP (melanocyte keratinocyte transplant procedure)</intervention_name>
    <description>Each subject will have the melanocyte keratinocyte transplant procedure on 4 distinct areas using the two different techniques being studied (carbon dioxide laser and dermabrasion) and the two different dressings being studied (vaseline impregnated gauze and collagen dressing).</description>
    <arm_group_label>MKTP with CO2 Laser/Collagen Dressing</arm_group_label>
    <arm_group_label>MKTP with CO2 laser/vaseline gauze</arm_group_label>
    <arm_group_label>MKTP with dermabrasion/collagen dressing</arm_group_label>
    <arm_group_label>MKTP with dermabrasion/vaseline gauze</arm_group_label>
    <other_name>MKTP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Collagen Dressing</intervention_name>
    <description>Each subject will have MKTP on 4 distinct areas.  Two of these areas will be dressed with a collagen dressing.</description>
    <arm_group_label>MKTP with CO2 Laser/Collagen Dressing</arm_group_label>
    <arm_group_label>MKTP with dermabrasion/collagen dressing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Vaseline Impregnated Gauze</intervention_name>
    <description>Each subject will have MKTP on 4 distinct areas of depigmented skin.  Two of these areas will be dressed with vaseline impregnated gauze.</description>
    <arm_group_label>MKTP with CO2 laser/vaseline gauze</arm_group_label>
    <arm_group_label>MKTP with dermabrasion/vaseline gauze</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Carbon Dioxide Laser</intervention_name>
    <description>Each subject will have MKTP on 4 distinct areas of depigmented skin.  Two of these areas will be de-epithelialized using a carbon dioxide laser.</description>
    <arm_group_label>MKTP with CO2 Laser/Collagen Dressing</arm_group_label>
    <arm_group_label>MKTP with CO2 laser/vaseline gauze</arm_group_label>
    <other_name>CO2 laser</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dermabrasion</intervention_name>
    <description>Each subject will have MKTP on 4 distinct areas of depigmented skin.  Two of these areas will be de-epithelialized using dermabrasion.</description>
    <arm_group_label>MKTP with dermabrasion/collagen dressing</arm_group_label>
    <arm_group_label>MKTP with dermabrasion/vaseline gauze</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Depigmented patches of skin

        Exclusion Criteria:

          -  History of Acral Vitiligo

          -  Unstable Vitiligo, defined as new areas of depigmentation or enlarging areas of
             depigmentation within the last 6 months

          -  History of hypertrophic scarring or keloids

          -  History of koebnerization (new patches of vitiligo at sites of injury or trauma)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Iltefat H Hamzavi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Henry Ford Dermatology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Melissa S Williams, MD</last_name>
    <phone>313-916-6964</phone>
    <email>mwilli33@hfhs.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Prescilia N Isedeh, MD</last_name>
    <phone>313-916-6964</phone>
    <email>pisedeh1@hfhs.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Henry Ford Dermatology</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa S Williams, MD</last_name>
      <phone>313-916-6964</phone>
      <email>mwilli33@hfhs.org</email>
    </contact>
    <contact_backup>
      <last_name>Prescilia N Isedeh, MD</last_name>
      <phone>313-916-6964</phone>
      <email>pisedeh1@hfhs.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 14, 2014</lastchanged_date>
  <firstreceived_date>January 10, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Henry Ford Health System</investigator_affiliation>
    <investigator_full_name>Iltefat Hamzavi</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vitiligo</mesh_term>
    <mesh_term>Hypopigmentation</mesh_term>
    <mesh_term>Cicatrix</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Petrolatum</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
